More than 3.5 million menopausal women are in the UK workforce right now...
making conversations about menopause support in the workplace essential.

Half of the UK workforce will enter menopause in their lifetime. 1 million menopausal women left their jobs due to a combination of their symptoms and a lack of workplace support.
At Hertility, we believe the key to supporting and retaining talent is education, policy and specialist care.

In this webinar, Hertility's CEO and Founder Helen O’Neill on World Menopause Day to highlight the importance of support for Menopause in the Workplace. In discussion with Key Opinion Leaders in this space.

The following is covered:
The impact of menopause symptoms on employees
Workplace support for menopausal women
Menopausal policies and how to introduce them in your workplace
Facilitating workplace conversations about the menopause
A sneak peek into Hertility's new Menopause Monit-HER Test
The session ends with a Q&A session with questions from the audience.

Our Panel:
Landy Slattery, Creative Director Channel 4
Landy is a founder and ex co-chair of 4women, the gender equality network at Channel 4. In 2018 4Women launched the media industry’s first menopause policy and one year later made their policy public for anyone else to use. The policy to date has had 3400 downloads! 4Women is one of a strong network of employee groups working towards equality and inclusivity at Channel 4. Landy’s other role is Creative Director of All 4, 4creative, which involves looking after the marketing creative for Channel 4’s on-demand platform ALL 4.

Carly Tait, Paralympian & DE&I Lead
Carly Tait (PLY) is a Paralympian and D&I Lead who has worked with global brands and businesses to shape and implement their DEI ambitions. Carly is a passionate advocate for intersectional inclusion and brings her lived experience as someone who went into menopause at 30. She is now dedicated to improving the awareness and allyship around menstrual, hormonal and fertility health.

Dr Helen O'Neill, CEO of Hertility
Dr Helen is a Lecturer in Reproductive and Molecular Genetics at University College London and a leading expert in reproductive science. She has a MSc in Prenatal Genetics and Fetal Medicine and a PhD in Stem Cell Biology from UCL. Her research focuses on pre-implantation embryo development and the use of CRISPR genome editing to assess the understanding and treatment of disorders of infertility.
She was awarded in the Top Twenty Women in Data in 2019 and one of the Top Fifty Inspirational Women in Technology in 2022. She is also a Lecturer at University College London where she lectures both masters and medical students in reproductive and molecular genetics and is a thought leader in reproductive science speaking at various conferences and TedX events.

About Hertility
Hertility is a digital health company shaping the future of reproductive healthcare. We’re working with the world’s most forward-thinking companies to proactively support employees across every life stage with end-to-end care spanning women’s health, men’s health, fertility & family-forming & menopause.
The workplace wasn’t designed with women in mind, we’re here to change that. We support employers to attract, support and retain a diverse, thriving and innovative workforce with expert-led CPD-accredited educational workshops, comprehensive at-home testing, telemedicine and treatment and workplace infrastructure and policy review.
We’ve spent years becoming the most regulated at-home reproductive care provider, including being fully CQC-approved, MHRA-regulated and CE-marked, and we’re committed to providing the highest quality service complete with a clinical care team with unparalleled education and training and a vetted network of partner clinics for further specialist treatment.